MedTrace Logo

Cardiovascular Effects of Carbetocin Given During Elective Cesarean

NCT02636816 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2016-11-17

No results posted yet for this study

Summary

The investigators are investigating whether slow administration of carbetocin is tolerated by patients better than if it is administered quickly, with respect to side effects such as headache, nausea, vomiting and facial flushing.

Conditions

  • Effect of Carbetocin on Cardiovascular System
  • Pregnancy

Interventions

DRUG

carbetocin

drug used to increase the tone of uterine muscle to prevent post partum hemorrhage after cesarean delivery.

Sponsors & Collaborators

  • Edwards Lifesciences

    collaborator INDUSTRY

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Vit Gunka, MD FRCPC · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02636816 on ClinicalTrials.gov